{"success":true,"data":{"pressRelease":{"id":"22370","rtpr_id":"nNFCPzZ5x","ticker":"NKTR","exchange":"NASDAQ","all_tickers":["NKTR"],"title":"NEKTAR DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - NKTR","author":"Newsfile Corp","published_at":"2026-05-06T01:27:16.962Z","article_body":"New York, New York--(Newsfile Corp. - May 5, 2026) - WHY: Rosen Law Firm, a\nglobal investor rights law firm, reminds purchasers of securities of Nektar\nTherapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025,\nboth dates inclusive (the \"Class Period\"), of the important May 5, 2026 lead\nplaintiff deadline.\n\nSO WHAT: If you purchased Nektar securities during the Class Period you may be\nentitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the Nektar class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55599 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than May 5, 2026. A\nlead plaintiff is a representative party acting on behalf of other class\nmembers in directing the litigation.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually litigate securities class actions, but are\nmerely middlemen that refer clients or partner with law firms that actually\nlitigate the cases. Be wise in selecting counsel. The Rosen Law Firm\nrepresents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved, at that time, the largest ever securities class action\nsettlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS\nSecurities Class Action Services for number of securities class action\nsettlements in 2017. The firm has been ranked in the top 4 each year since\n2013 and has recovered hundreds of millions of dollars for investors. In 2019\nalone the firm secured over $438 million for investors. In 2020, founding\npartner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many\nof the firm's attorneys have been recognized by Lawdragon and Super Lawyers.\n\nDETAILS OF THE CASE: According to the lawsuit, defendants made false and/or\nmisleading statements and/or failed to disclose that: (1) enrollment in the\nREZOLVE-AA trial had not followed applicable instructions and protocol\nstandards; (2) the foregoing was likely to have a significant negative impact\non the REZOLVE-AA trial's results; (3) accordingly, the REZOLVE-AA trial's\noverall integrity and prospects were overstated; and (4) as a result,\ndefendants' public statements were materially false and misleading at all\nrelevant times. When the true details entered the market, the lawsuit claims\nthat investors suffered damages.\n\nTo join the Nektar class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55599 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\n\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/295978","article_body_html":"","raw_payload":{"data":{"id":"nNFCPzZ5x","title":"NEKTAR DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - NKTR","author":"Newsfile Corp","ticker":"NKTR","created":"2026-05-06T01:27:16.962Z","tickers":["NKTR"],"exchange":"NASDAQ","article_body":"New York, New York--(Newsfile Corp. - May 5, 2026) - WHY: Rosen Law Firm, a\nglobal investor rights law firm, reminds purchasers of securities of Nektar\nTherapeutics (NASDAQ: NKTR) between February 26, 2025 and December 15, 2025,\nboth dates inclusive (the \"Class Period\"), of the important May 5, 2026 lead\nplaintiff deadline.\n\nSO WHAT: If you purchased Nektar securities during the Class Period you may be\nentitled to compensation without payment of any out of pocket fees or costs\nthrough a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the Nektar class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55599 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than May 5, 2026. A\nlead plaintiff is a representative party acting on behalf of other class\nmembers in directing the litigation.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually litigate securities class actions, but are\nmerely middlemen that refer clients or partner with law firms that actually\nlitigate the cases. Be wise in selecting counsel. The Rosen Law Firm\nrepresents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved, at that time, the largest ever securities class action\nsettlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS\nSecurities Class Action Services for number of securities class action\nsettlements in 2017. The firm has been ranked in the top 4 each year since\n2013 and has recovered hundreds of millions of dollars for investors. In 2019\nalone the firm secured over $438 million for investors. In 2020, founding\npartner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many\nof the firm's attorneys have been recognized by Lawdragon and Super Lawyers.\n\nDETAILS OF THE CASE: According to the lawsuit, defendants made false and/or\nmisleading statements and/or failed to disclose that: (1) enrollment in the\nREZOLVE-AA trial had not followed applicable instructions and protocol\nstandards; (2) the foregoing was likely to have a significant negative impact\non the REZOLVE-AA trial's results; (3) accordingly, the REZOLVE-AA trial's\noverall integrity and prospects were overstated; and (4) as a result,\ndefendants' public statements were materially false and misleading at all\nrelevant times. When the true details entered the market, the lawsuit claims\nthat investors suffered damages.\n\nTo join the Nektar class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55599 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\n\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/295978"},"type":"article","timestamp":"2026-05-06T01:27:16.997116889Z","server_sent_at_ms":1778030836997},"received_at":"2026-05-06T01:27:17.050Z","source_url":"https://www.newsfilecorp.com/release/295978"},"analysis":{"id":"16593","press_release_id":"22370","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Rosen Law Firm issued a solicitation notice reminding Nektar Therapeutics investors of the May 5, 2026 lead plaintiff deadline in a securities class action.\n\nThe lawsuit alleges that Nektar misled investors regarding the integrity of the REZOLVE-AA trial, specifically concerning enrollment standards and protocol.\n\nThis release is a plaintiff-firm solicitation for lead plaintiffs and is not an issuer disclosure; no class has been certified yet.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Phillip Kim","role":"Attorney"},{"name":"Laurence Rosen","role":"Founding Partner"}],"products":["REZOLVE-AA"],"companies":[{"name":"Rosen Law Firm, P.A.","relationship":"plaintiff law firm"},{"name":"Nektar Therapeutics","ticker":"NKTR","relationship":"target"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation issued by Rosen Law Firm. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"NKTR"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Rosen Law Firm issued a solicitation notice reminding Nektar Therapeutics investors of the May 5, 2026 lead plaintiff deadline in a securities class action.\n\nThe lawsuit alleges that Nektar misled investors regarding the integrity of the REZOLVE-AA trial, specifically concerning enrollment standards and protocol.\n\nThis release is a plaintiff-firm solicitation for lead plaintiffs and is not an issuer disclosure; no class has been certified yet.","key_figures":{},"named_entities":{"people":[{"name":"Phillip Kim","role":"Attorney"},{"name":"Laurence Rosen","role":"Founding Partner"}],"products":["REZOLVE-AA"],"companies":[{"name":"Rosen Law Firm, P.A.","relationship":"plaintiff law firm"},{"name":"Nektar Therapeutics","ticker":"NKTR","relationship":"target"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:511026a279f8af46","schema_hash":"sha256:96555d0809de301c","created_at":"2026-05-06T10:01:56.387Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":209740,"modelName":"glm-4.7"}}